Using Replicel technology with a license that's only good for Asia
Replicel Is On Fire Lately — Data In Feb.
- Thread starter That Guy
- Start date
Using Replicel technology with a license that's only good for Asia
thomps1523
Established Member
- Reaction score
- 298
Agreed I definitely want it readily available in more areas in Asia, but I think if a big company like shiseido can prove efficacy it'll be an easier ride for replicel to get funding to speed the process in North America, don't you?
- Reaction score
- 4,609
So ? Just fly to japan and receive the injections
br1
Senior Member
- Reaction score
- 2,163
Oh there you go, I had missed this one. Thanks.
I dont think there is a problem in their tech. look at samumed it is valued around a billion and doesnt have any trouble of attracting investors. there is a recent post about a new investor. comparing the two I would say repliel provided much more efficacy than samumed and is going to hit the market sooner. the problem isnt just the product,I guess it has to do with the people who work on marketing their tech to investors.
- Reaction score
- 636
- Reaction score
- 99
@Grasshüpfer does that mean something for us? (related to the product efficacy/release date)
Gasshopper maybe has stock and wants others to buy stock too so he promotes the stock.
He has no idea if the product is efficacious. If it isn't efficacious then the stock will drop.
thomps1523
Established Member
- Reaction score
- 298
Bro will you please quit accusing everyone of being someone else, or having stock in a company just because they talk about them? Good grief!
- Reaction score
- 14
As if we could actually change the stock price as a forum
So then do you think that if Replicel stockholders talk-up Replicel at this sit then they can't also talk up Replicel at other places?
Last edited:
- Reaction score
- 14
So if I support replicel's stock doing well then I'm also a stockholder?
- Reaction score
- 15
Hello. I'm new to this forum. Could I please have a link to those initial studies?
No, not necessarily. I don't know if you're a Replicel stockholder. That's why I said "maybe" you're a stockholder. And maybe you're not.
Last edited:
If it works we can fly to Asia.
Last edited:
- Reaction score
- 119
WereInaRecession
Member
- Reaction score
- 30
Still annoying to see those 3/16 lose hair for some reason.that's like 20% miss rate.
I hope the ones that did respond tho kept going up or maintained. We will see soon. Problem is even if they didn't repicel can always say its just phase one and were just testing mainly for safety so lets do another 5 year trial because were still ironing out the kinks to test what is optimal dosage. That would set us back way past the 2018 date
I hope the ones that did respond tho kept going up or maintained. We will see soon. Problem is even if they didn't repicel can always say its just phase one and were just testing mainly for safety so lets do another 5 year trial because were still ironing out the kinks to test what is optimal dosage. That would set us back way past the 2018 date
- Reaction score
- 15
Quick question about the Japanese market and their safety guidelines in regards to the pharmaceutical industry. Is it generally faster over there to get a product to market? By that I mean, faster than what we have here with phase I-III and everything else?
I already travel to Japan once a year so this would be convenient for me. I don't know if this would be doable though. If this thing comes out and it produces the results we're all hoping for, my guess is there will be a pretty long waiting list for both locals and foreigners.
I already travel to Japan once a year so this would be convenient for me. I don't know if this would be doable though. If this thing comes out and it produces the results we're all hoping for, my guess is there will be a pretty long waiting list for both locals and foreigners.